What is the recommended approach to managing a chronic condition, such as diabetes or hypertension, in an adult patient, in line with the Choose Wisely campaign?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 21, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Managing Chronic Conditions Aligned with Choose Wisely Principles

Implement team-based care with structured medication titration protocols, target blood pressure <140/90 mmHg using ACE inhibitors or ARBs as first-line agents, target HbA1c 7.5-8.0% using metformin initially, and prioritize lifestyle interventions before medication intensification while avoiding routine unnecessary testing. 1

Core Framework: Team-Based Care Model

The foundation of managing diabetes and hypertension should be team-based care as the primary delivery system, with designated team members implementing medication titration algorithms under physician supervision rather than relying solely on physician-driven care. 1 This approach directly addresses the Choose Wisely principle of efficient resource utilization while maintaining quality outcomes.

  • Create protocols for timely patient contact through telephone, secure messaging, or urgent appointments to enable non-physician team members to manage routine adjustments. 1
  • Designate specific team members (nurses, pharmacists, care coordinators) to implement pre-approved medication titration algorithms rather than requiring physician involvement for every adjustment. 1

Blood Pressure Management Algorithm

Initiate pharmacologic therapy immediately alongside lifestyle modifications for confirmed office BP ≥140/90 mmHg—do not delay treatment waiting for lifestyle changes alone. 1

First-Line Agent Selection

  • Use ACE inhibitors or ARBs as preferred initial agents for all patients with diabetes and hypertension, particularly those with proteinuria, microalbuminuria, or left ventricular hypertrophy. 1
  • Target BP <140/90 mmHg for most adults with diabetes. 1
  • Avoid lowering systolic BP to <120 mmHg in older diabetics, as this causes harm without cardiovascular benefit and may worsen cerebral perfusion. 2

Monitoring Considerations

  • Check standing BP at each visit to monitor for orthostatic hypotension, especially in elderly patients. 3, 2
  • Titrate medications gradually to avoid orthostatic hypotension in cognitively impaired or elderly patients. 3

Glycemic Control Algorithm

Target HbA1c <7.5% for most adults with diabetes, relaxing to 7.5-8.0% or even 8.0-8.5% for older adults with multiple comorbidities or limited life expectancy. 1, 3, 2

First-Line Agent Selection

  • Use metformin as the first-line agent for type 2 diabetes unless contraindicated by renal function. 1, 3
  • Avoid sulfonylureas in elderly or cognitively impaired patients due to prolonged half-life and escalating hypoglycemia risk. 3, 2
  • Consider SGLT inhibitors and GLP-1 receptor agonists when initiating treatment, as they reduce BP, enhance kidney function, and lower cardiovascular disease risk. 4

Critical Safety Monitoring

  • Assess hypoglycemia risk and awareness at every visit, as cognitive impairment and advanced age increase vulnerability to severe hypoglycemic episodes that can worsen cognition. 3, 2
  • Never target HbA1c <7% in older adults with multiple comorbidities—aggressive control increases hypoglycemia risk without proportionate benefit. 2

Lifestyle Interventions (Mandatory for All Patients)

Initiate lifestyle modifications for all patients with BP >120/80 mmHg or diabetes, regardless of medication status—these are not optional or secondary interventions. 1

  • Weight loss through caloric restriction 1
  • DASH dietary pattern implementation 1
  • Regular physical activity (supervised walking programs and aerobic exercise improve vascular function) 1, 2
  • Alcohol moderation 1
  • Smoking cessation counseling 1
  • Ensure optimal protein intake to prevent sarcopenia in older adults with diabetes 2

Cardiovascular Risk Reduction Beyond Glucose and BP

  • Target LDL-C <55 mg/dL or ≥50% reduction for patients with diabetes and very high cardiovascular risk using statin therapy. 1, 2
  • Initiate aspirin 81-325 mg daily for secondary stroke prevention in older adults with diabetes and established cardiovascular disease. 2

Choose Wisely Principles: What to Avoid

Avoid routine cardiac screening in asymptomatic patients with diabetes—instead perform careful history and assess cardiovascular risk factors rather than ordering unnecessary tests. 1 This directly addresses the Choose Wisely campaign's emphasis on reducing low-value care. 5

Additional Unnecessary Testing to Avoid

  • Do not perform routine pre-operative testing without clinical indication—awareness campaigns alone are insufficient; system-level changes in ordering processes are required. 5
  • Do not interrupt successful antihypertensive therapy when patients reach 80 years of age. 2

Essential Screening and Monitoring (High-Value Care)

  • Screen annually for diabetic kidney disease by assessing eGFR and urinary albumin:creatinine ratio. 1
  • Monitor for orthostatic hypotension by measuring BP in erect posture at each visit in elderly patients. 2

Patient-Centered Implementation

  • Engage patients in determining individual BP and glycemic targets based on life expectancy, comorbidities, treatment burden, and patient preferences. 1
  • Involve caregivers in medication management and safety monitoring for patients with cognitive impairment to address concerns without institutionalization. 3
  • Use patient-centered communication incorporating literacy assessment and cultural barriers. 1

Common Pitfalls

  • Relying solely on awareness-raising and guideline revision is insufficient—behavior change requires system-level interventions such as electronic order modifications, decision support tools, and performance monitoring. 5
  • Failing to relax glycemic targets in elderly or complex patients leads to preventable hypoglycemia. 3, 2
  • Aggressive BP lowering in older adults can worsen cerebral perfusion and outcomes. 2

References

Guideline

Managing Chronic Conditions with Team-Based Care

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Management of Microvascular Brain Changes in Older Adults with Vascular Risk Factors

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Management of Cognitive Impairment in Elderly Patients with Diabetes and Hypertension

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

The connection between hypertension and diabetes and their role in heart and kidney disease development.

Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences, 2024

Research

What influences clinicians to choose wisely?

The New Zealand medical journal, 2019

Related Questions

What is the recommended approach to managing a chronic condition, such as diabetes or hypertension, in an adult patient, in line with the Choose Wisely campaign?
What are the primary aims for managing diabetes and hypertension?
What health recommendations are advised for a 65-year-old with hypertension and diabetes?
What is the appropriate initial management for a patient with uncontrolled Diabetes Mellitus, Hypertension, and Dyslipidemia, with elevated liver enzymes?
What is the best course of management for a patient with a 1-year history of abdominal pain and abdominal fullness, who also has a history of diabetes (DM) and hypertension (HTN)?
How soon after administering intravenous (IV) insulin to a critically ill adult patient should blood glucose (BG) levels be checked?
What is the recommended dosage of pantoprazole (proton pump inhibitor) for a child with a gastric ulcer?
What is flow cytometry?
What is the role of Proconvertase subtilisin/kexin type 1 (PCSK1) inhibitors, such as finerenone (finerenone), in the management of proteinuria in patients with chronic kidney disease, particularly those with diabetic nephropathy?
What are the recommended treatment options for a patient with breast cancer or at high risk of developing breast cancer, considering their individual risk factors, medical history, and preferences, as part of the Choosing Wisely (CW) trial for breast cancer management?
What could cause immediate symptoms of red face, head pain, chest tightness, and skin redness after administering 1 ml of FCM (Fluorescein Contrast Medium) intravenously?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.